Get the latest market trends in your inbox
Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Illustration: Sarah Grillo/Axios
Even if the Trump administration is able to implement its latest plan to let people import prescription drugs from Canada, it probably won't make much of a difference, experts say.
Between the lines: Canada doesn't have nearly enough drugs to meet American demand, and even if it did, it doesn't want to send them to us at the expense of its own market.
Details: The administration unveiled two paths to importation yesterday.
- States, wholesalers or pharmacists can ask the federal government to approve a demonstration project, only including certain drugs, only from Canada.
- Drug companies could import their own products from other countries, at the lower prices they charge there.
Yes, but: "Canada is a much smaller country than is the United States ... and at least some stakeholders have argued that the Canadian market cannot supply medicines to the much larger US market without experiencing drug shortages," Washington University law professor Rachel Sachs wrote in Health Affairs over the summer.
Go deeper: We can't just take Canada's drugs